HELIOSTAR™ Radiofrequency Balloon Ablation Catheter Launched by Biosense Webster in Europe
On October 12, 2022, Biosense Webster, a part of Johnson & Johnson Medical technology, announced the launch of HELIOSTAR™ Balloon Ablation Catheter, the first radiofrequency balloon ablation catheter in Europe. With personalized energy delivery and a single integrated 3D mapping solution, the HELIOSTAR™ Balloon Ablation Catheter's innovative one-shot balloon technology provides pulmonary vein isolation in 12 seconds. The HELIOSTAR™ Balloon Ablation Catheter, when used with a compatible multi-channel RF generator, is indicated for cardiac ablati...
